AVVINITY Trademark

Trademark Overview


On Wednesday, August 25, 2021, a trademark application was filed for AVVINITY with the United States Patent and Trademark Office. The USPTO has given the AVVINITY trademark a serial number of 79323648. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, January 10, 2023. This trademark is owned by Avvinity Therapeutics Limited. The AVVINITY trademark is filed in the Treatment & Processing of Materials Services and Computer & Software Services & Scientific Services categories with the following description:

Custom manufacture of therapeutic drugs, including custom manufacture of antibody based therapies and cancer therapies

Scientific and technological services and research and design relating thereto; industrial analysis and research services; medical and pharmaceutical research services; biological research; biotechnology testing services; scientific research in the field of oncology; development of pharmaceutical preparations and medicines; development of new cancer therapies; research and development of vaccines and medicines; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; clinical trials; clinical trial design for vaccines and gene therapy; scientific research in human and animal cell therapy; research and development services relating to targeting therapies to individuals; scientific research into preparations for manipulating and adapting human and animal cells; software as a service; providing a bioinformatics platform for manufacturing therapeutics; scientific services relating to the discovery, preclinical and clinical development of th...
avvinity

General Information


Serial Number79323648
Word MarkAVVINITY
Filing DateWednesday, August 25, 2021
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, January 10, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesCustom manufacture of therapeutic drugs, including custom manufacture of antibody based therapies and cancer therapies
Goods and ServicesScientific and technological services and research and design relating thereto; industrial analysis and research services; medical and pharmaceutical research services; biological research; biotechnology testing services; scientific research in the field of oncology; development of pharmaceutical preparations and medicines; development of new cancer therapies; research and development of vaccines and medicines; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; clinical trials; clinical trial design for vaccines and gene therapy; scientific research in human and animal cell therapy; research and development services relating to targeting therapies to individuals; scientific research into preparations for manipulating and adapting human and animal cells; software as a service; providing a bioinformatics platform for manufacturing therapeutics; scientific services relating to the discovery, preclinical and clinical development of therapeutic products; research and development of new products for others; development of pharmaceutical products for others; information, advisory and consultancy services relating to the aforesaid

Classification Information


International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateTuesday, October 26, 2021
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, October 26, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAvvinity Therapeutics Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Tuesday, January 30, 2024FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, January 10, 2024FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, January 10, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, April 12, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, March 22, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, March 22, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, January 10, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Tuesday, January 10, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Tuesday, January 10, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, July 19, 2022REFUSAL PROCESSED BY IB
Monday, June 27, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, June 27, 2022REFUSAL PROCESSED BY MPU
Tuesday, June 7, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, June 6, 2022NON-FINAL ACTION WRITTEN
Tuesday, May 31, 2022ASSIGNED TO EXAMINER
Saturday, October 30, 2021APPLICATION FILING RECEIPT MAILED
Tuesday, October 26, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 22, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB